blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1351681

EP1351681 - IMPLANTABLE DEVICE CONTAINING RESORBABLE MATRIX MATERIAL AND ANTI-PROLIFERATIVE DRUGS FOR PREVENTING OR TREATING FAILURE OF HEMODIALYSIS VASCULAR ACCESS AND OTHER VASCULAR GRAFTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.07.2011
Database last updated on 24.08.2024
Most recent event   Tooltip27.09.2013Lapse of the patent in a contracting state
New state(s): TR		published on 30.10.2013  [2013/44]
Applicant(s)For all designated states
Vascular Therapies, LLC
201 East 87th Street, Apt. 14C
New York, NY 10128 / US
[2003/42]
Inventor(s)01 / IYER, Sriram, S.
201 East 87th Street, Apt. 14C
New York, NY 10128 / US
02 / KIPSHIDZE, Nicholas, N.
345 E. 80th Street, Apt. 25B
New York, NY 10021 / US
03 / NIKOLAYCHIK, Victor, V.
112 East Friestadt Street, Apt. F
Mequon, WI 53092 / US
 [2003/42]
Representative(s)Watson, Robert James, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2003/42]Watson, Robert James, et al
Mewburn Ellis York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date02718844.016.01.2002
[2003/42]
WO2002US01375
Priority number, dateUS20010262132P16.01.2001         Original published format: US 262132 P
[2003/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02062335
Date:15.08.2002
Language:EN
[2002/33]
Type: A2 Application without search report 
No.:EP1351681
Date:15.10.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 15.08.2002 takes the place of the publication of the European patent application.
[2003/42]
Type: B1 Patent specification 
No.:EP1351681
Date:15.09.2010
Language:EN
[2010/37]
Search report(s)International search report - published on:EP27.12.2002
ClassificationIPC:A61K31/395, A61K31/337, A61K38/13, A61K38/08, A61K31/727, A61K31/122, A61K31/573, A61K47/36, A61K47/42, A61P43/00
[2003/42]
CPC:
A61K31/436 (EP,US); A61K31/122 (EP,US); A61K31/337 (EP,US);
A61K31/395 (EP,US); A61K31/573 (EP,US); A61K31/727 (EP,US);
A61K9/0024 (EP,US); A61L27/20 (US); A61L27/225 (US);
A61L27/44 (US); A61L27/54 (US); A61L31/16 (EP,US);
A61M1/3655 (EP,US); A61M39/0247 (EP,US); A61P31/00 (EP);
A61P37/06 (EP); A61P41/00 (EP); A61P43/00 (EP);
A61P7/02 (EP); A61P7/08 (EP); A61P9/00 (EP);
A61P9/10 (EP); A61L2300/204 (US); A61L2300/252 (US);
A61L2300/416 (EP,US); A61M1/16 (EP,US); A61M2039/0258 (EP,US);
A61M2039/0261 (EP,US); A61M2202/0468 (EP,US); A61M2202/0478 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/42]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:IMPLANTIERBARE VORRICHTUNG ENTHALTEND RESORBIERBARES MATRIXMATERIAL UND ANTIPROLIFERATIVE WIRKSTOFFE ZUR VORBEUGUNG ODER BEHANDLUNG VON VERSAGEN VASKULÄRER HÄMODIALYSEZUGÄNGE UND ANDERER VASKULÄRER TRANSPLANTATE[2003/42]
English:IMPLANTABLE DEVICE CONTAINING RESORBABLE MATRIX MATERIAL AND ANTI-PROLIFERATIVE DRUGS FOR PREVENTING OR TREATING FAILURE OF HEMODIALYSIS VASCULAR ACCESS AND OTHER VASCULAR GRAFTS[2003/42]
French:APPAREIL ET METHODES DE PREVENTION OU DE TRAITEMENT EN CAS D'ECHEC D'UN ACCES VASCULAIRE POUR HEMODIALYSE ET EN CAS DE REJET DE GREFFONS VASCULAIRES[2003/42]
Entry into regional phase07.08.2003National basic fee paid 
07.08.2003Designation fee(s) paid 
07.08.2003Examination fee paid 
Examination procedure05.08.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.08.2003Amendment by applicant (claims and/or description)
07.08.2003Examination requested  [2003/42]
12.03.2007Despatch of a communication from the examining division (Time limit: M04)
23.07.2007Reply to a communication from the examining division
26.10.2007Despatch of a communication from the examining division (Time limit: M04)
05.03.2008Reply to a communication from the examining division
18.09.2008Despatch of a communication from the examining division (Time limit: M06)
24.03.2009Reply to a communication from the examining division
26.11.2009Date of oral proceedings
17.12.2009Date of oral proceedings
05.02.2010Cancellation of oral proceeding that was planned for 12.02.2010
12.02.2010Date of oral proceedings (cancelled)
08.03.2010Communication of intention to grant the patent
19.07.2010Fee for grant paid
19.07.2010Fee for publishing/printing paid
Divisional application(s)EP10176383.7  / EP2314293
EP17150201.6
Opposition(s)16.06.2011No opposition filed within time limit [2011/34]
Fees paidRenewal fee
26.01.2004Renewal fee patent year 03
20.01.2005Renewal fee patent year 04
25.01.2006Renewal fee patent year 05
29.01.2007Renewal fee patent year 06
25.01.2008Renewal fee patent year 07
30.01.2009Renewal fee patent year 08
25.01.2010Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.09.2010
BE15.09.2010
CY15.09.2010
DK15.09.2010
FI15.09.2010
IT15.09.2010
NL15.09.2010
SE15.09.2010
TR15.09.2010
GR16.12.2010
ES26.12.2010
IE16.01.2011
LU16.01.2011
PT17.01.2011
CH31.01.2011
LI31.01.2011
MC31.01.2011
[2013/44]
Former [2013/25]AT15.09.2010
BE15.09.2010
CY15.09.2010
DK15.09.2010
FI15.09.2010
IT15.09.2010
NL15.09.2010
SE15.09.2010
GR16.12.2010
ES26.12.2010
IE16.01.2011
LU16.01.2011
PT17.01.2011
CH31.01.2011
LI31.01.2011
MC31.01.2011
Former [2012/08]AT15.09.2010
BE15.09.2010
CY15.09.2010
DK15.09.2010
FI15.09.2010
IT15.09.2010
NL15.09.2010
SE15.09.2010
GR16.12.2010
ES26.12.2010
IE16.01.2011
PT17.01.2011
CH31.01.2011
LI31.01.2011
MC31.01.2011
Former [2011/48]AT15.09.2010
BE15.09.2010
CY15.09.2010
DK15.09.2010
FI15.09.2010
IT15.09.2010
NL15.09.2010
SE15.09.2010
GR16.12.2010
ES26.12.2010
PT17.01.2011
CH31.01.2011
LI31.01.2011
MC31.01.2011
Former [2011/40]AT15.09.2010
BE15.09.2010
CY15.09.2010
DK15.09.2010
FI15.09.2010
IT15.09.2010
NL15.09.2010
SE15.09.2010
GR16.12.2010
ES26.12.2010
PT17.01.2011
MC31.01.2011
Former [2011/31]AT15.09.2010
BE15.09.2010
CY15.09.2010
FI15.09.2010
IT15.09.2010
NL15.09.2010
SE15.09.2010
GR16.12.2010
ES26.12.2010
PT17.01.2011
Former [2011/24]AT15.09.2010
CY15.09.2010
FI15.09.2010
NL15.09.2010
SE15.09.2010
GR16.12.2010
PT17.01.2011
Former [2011/15]AT15.09.2010
CY15.09.2010
FI15.09.2010
SE15.09.2010
GR16.12.2010
Former [2011/13]AT15.09.2010
CY15.09.2010
FI15.09.2010
Former [2011/10]AT15.09.2010
FI15.09.2010
Former [2011/08]AT15.09.2010
Cited inInternational search[X]WO9323013  (NEW ENGLAND DEACONESS HOSPITAL [US]) [X] 2-9,11,15-19,21-31 * page 1, lines 15-21 * * page 5, line 25 - page 6, line 2 * * page 14, line 28 - page 15, line 2 *;
 [X]US5486524  (FAILLI AMEDEO A [US], et al) [X] 2-9,11,15-19,21-31 * column 1, lines 63-66 * * column 10, line 20 *;
 [X]US5527532  (EDELMAN ELAZER R [US], et al) [X] 2-9,11,15-19,21-31 * column 3, lines 48-54 * * column 4, lines 41-44 * * column 4, line 56 - column 5, line 6 * * column 5, lines 16-22 * * column 4, lines 32-38 *;
 [X]US5766584  (EDELMAN ELAZER R [US], et al) [X] 2-9,11,15-19,21-31 * column 2, line 41 * * column 3, line 6 * * column 3, line 62 * * column 4, line 2 * * column 2, lines 54-62 * * column 4, lines 30,31,44,45,54 *;
 [X]US6328762  (ANDERSON DIANE LEE [US], et al) [X] 2-9,11,15-19,21-31 * column 3, lines 39-48; claim 23 * * column 2, line 63 - column 3, line 2 * * column 3, lines 7-11 *;
 [E]WO0236054  (SIROLIMED LLC [US]) [E] 2-9,11,15-19,21-31 * page 2, lines 7-9,16,17 * * page 3, line 20 ** page 9, lines 17-19 *;
 [X]  - EDELMAN^A E R ET AL, "Perivascular graft heparin delivery using biodegradable polymer wraps", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, (20001115), vol. 21, no. 22, ISSN 0142-9612, pages 2279 - 2286, XP004210285 [X] 2-9,11,15-19,21-31 * page 2280, column 1, paragraph L * * page 2283, column 2, paragraph L - page 2284, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0142-9612(00)00154-X
 [X]  - HIRIGOYEN M B ET AL, "Periadventitial delivery of heparin in the prevention of microvenous thrombosis.", JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY: OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS. UNITED STATES SEP 1996, (199609), vol. 54, no. 9, ISSN 0278-2391, pages 1097 - 1102, XP001097380 [X] 2-9,11,15-19,21-31 * p.1097 "Purpose" * * page 1099; figure 3 *

DOI:   http://dx.doi.org/10.1016/S0278-2391(96)90169-X
by applicantUS4164559
 US4409332
 US6162247
 US6206931
 US6323184
    - PRICE, P. ET AL., "Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves", ATHEROSCLER THROMB VASC BIOL, (1998), vol. 18, pages 1400 - 1407, XP000960945
    - HERMANN, S.M. ET AL., "Polymorphisms of the human matrix Gla-protein gene (MGP) vascular calcification and myocardial infarction", ARTERIOSCLER THROMB VASE BIOL., (2000), vol. 20, pages 2836 - 2893
    - PRICE P. ET AL., "Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves", ATHEROSCLER THROMB. VASC. BIOL., (1998), vol. 18, pages 1400 - 1407, XP000960945
    - HERMANN S.M. ET AL., "Polymorphisms of the human matrix Gla-protein gene (MGP) vascular calcification and myocardial infarction", ARTERIOSCLER THROMB. VASC. BIOL., (2000), vol. 20, pages 2836 - 93
    - ALMIN, C.; CHUNLIN, H.; JULIANG, B. ET AL., "Antibiotic loaded chitosan bar. In vitro, in vivo study of a possible treatment for osteomyelitis", CLIN ORTHOL2, (199909), pages 239 - 247, XP009038846
    - YAO L; MIZUSHIGE K; MURAKAMI K ET AL., "Troglitozone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model", HEART, (2000), vol. 84, pages 209 - 210
    - NAKANO M; NAKAYAMA Y; KOHDA A ET AL., "Acute subcutaneous toxicity of SM-10500 in rats", KISOTO RINSHO, (1995), vol. 29, pages 1675 - 1699
    - FERRON GM; CONWAY WD; JUSKO WJ., "Lipophilic benzamide and anilide derivatives as high-performance liquid chromatography internal standard: application to sirolimus (rapamycin) determination", J CHROMATOGR B BIOMED SCI APPL, (199712), vol. 703, doi:doi:10.1016/S0378-4347(97)00415-5, pages 243 - 251, XP004100040

DOI:   http://dx.doi.org/10.1016/S0378-4347(97)00415-5
    - WACHOL-DREWEK Z; PFEIFER M; SCHOLL E., "Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and sponge containing gentamicin", BIOMATERIALS, (1996), vol. 17, doi:doi:10.1016/0142-9612(96)87654-X, pages 1733 - 1738, XP004032983

DOI:   http://dx.doi.org/10.1016/0142-9612(96)87654-X
    - MEHTA S; HUMPHREY JS; SCHENKMAN DI ET AL., "Gentamycin distribution from a collagen carrier", J ORTHOP. RES., (1996), vol. 14, doi:doi:10.1002/jor.1100140511, pages 749 - 754, XP055118622

DOI:   http://dx.doi.org/10.1002/jor.1100140511
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.